Phase 2, two-group, two-stage study of avelumab in patients (pts) with microsatellite stable (MSS), microsatellite instable (MSI), and polymerase epsilon (POLE) mutated recurrent/persistent endometrial cancer (EC).
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Panagiotis A. Konstantinopoulos, Joyce F. Liu, Weixiu Luo, Carolyn N. Krasner, Jeffrey Joseph Ishizuka, Allison Ann Gockley, Mary K. Buss, Susana M. Campos, Elizabeth Stover, Alexi A. Wright, Whitfield Board Growdon, Jennifer Curtis, Ariana Peralta, Patrice Basada, Roxanne Quinn, Kathryn P. Gray, Richard T. Penson, Stephen A. Cannistra, Gini F. Fleming, Ursula A. Matulonis
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2946858147